Application of lipid-regulating drugs in non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is a clinical syndrome which is characterized by diffuse fatty degeneration of hepatocytes without excessive use of alcohol, and it is one of the most common causes of abnormal liver function and chronic liver disease. Although the etiology and pathogenesis...
Main Authors: | CUI Ruibing, YAN Ming |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2015-07-01
|
Series: | Linchuang Gandanbing Zazhi |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=6633 |
Similar Items
-
Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease
by: Bilon Khambu, et al.
Published: (2018-09-01) -
Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease
by: Hsu-Wen Chao, et al.
Published: (2019-01-01) -
Application of lipid-regulating drugs in prevention and treatment of nonalcoholic fatty liver disease
by: LU Bingjie
Published: (2017-12-01) -
Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease
by: Sandra Steensels, et al.
Published: (2020-07-01) -
The Role of Lipid and Lipoprotein Metabolism in Non‐Alcoholic Fatty Liver Disease
by: Francesco Massimo Perla, et al.
Published: (2017-06-01)